Senior Patent Attorney
Matt Mulkeen is a senior patent attorney with Novartis Oncology based in East Hanover, New Jersey. He manages patent portfolios of marketed and pipeline products in the areas of small molecules and antibodies. His work at Novartis has related to various technical areas including epigenetics, immunotherapy, cell cycle arrest and kinase inhibition. He also advises on matters related to licensing, due diligence, freedom to operate, patent validity, patent office proceedings, market exclusivity and generic entry. Mulkeen graduated from Georgetown University Law Center in Washington DC, where he worked in private practice before joining Novartis.